426 related articles for article (PubMed ID: 32850813)
41. Systematic analysis competing endogenous RNA coexpression network as a potentially prediction prognostic biomarker for colon adenocarcinoma.
Xi J; Zhang H; Li Y; Su H; Chen X; Liang X
Medicine (Baltimore); 2022 Sep; 101(39):e30681. PubMed ID: 36181111
[TBL] [Abstract][Full Text] [Related]
42. The Construction and Analysis of Tumor-Infiltrating Immune Cells and ceRNA Networks in Bladder Cancer.
Jiang A; Liu N; Bai S; Wang J; Gao H; Zheng X; Fu X; Ren M; Zhang X; Tian T; Ruan Z; Yao Y; Liang X
Front Genet; 2020; 11():605767. PubMed ID: 33391354
[TBL] [Abstract][Full Text] [Related]
43. Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma.
Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Peng J; Xie Y
Front Cell Dev Biol; 2022; 10():971992. PubMed ID: 36081904
[No Abstract] [Full Text] [Related]
44. Using Tumor-Infiltrating Immune Cells and a ceRNA Network Model to Construct a Prognostic Analysis Model of Thyroid Carcinoma.
Zhang F; Yu X; Lin Z; Wang X; Gao T; Teng D; Teng W
Front Oncol; 2021; 11():658165. PubMed ID: 34141614
[TBL] [Abstract][Full Text] [Related]
45. Exploration of the relationship between tumor mutation burden and immune infiltrates in colon adenocarcinoma.
Ouyang R; Li Z; Peng P; Zhang J; Liu J; Qin M; Huang J
Int J Med Sci; 2021; 18(3):685-694. PubMed ID: 33437203
[No Abstract] [Full Text] [Related]
46. A construction and comprehensive analysis of the immune-related core ceRNA network and infiltrating immune cells in peripheral arterial occlusive disease.
Chen Z; Xu J; Zha B; Li J; Li Y; Ouyang H
Front Genet; 2022; 13():951537. PubMed ID: 36186432
[No Abstract] [Full Text] [Related]
47. Comprehensive Analysis of the Expression, Prognostic Value, and Immune Infiltration Activities of GABRD in Colon Adenocarcinoma.
Huang F; Wang Z; Zhu L; Lin C; Wang JX
Mediators Inflamm; 2023; 2023():8709458. PubMed ID: 37181811
[TBL] [Abstract][Full Text] [Related]
48. An integrated approach to understand fluid shear stress-driven and reactive oxygen species-mediated metastasis of colon adenocarcinoma through mRNA-miRNA-lncRNA-circRNA networks.
KrishnaPriya S; Omer S; Banerjee S; Karunagaran D; Suraishkumar GK
Mol Genet Genomics; 2022 Sep; 297(5):1353-1370. PubMed ID: 35831469
[TBL] [Abstract][Full Text] [Related]
49. Tumor Microenvironmental Competitive Endogenous RNA Network and Immune Cells Act as Robust Prognostic Predictor of Acute Myeloid Leukemia.
Cheng Y; Wang X; Qi P; Liu C; Wang S; Wan Q; Liu Y; Su Y; Jin L; Liu Y; Li C; Sang X; Yang L; Liu C; Duan H; Wang Z
Front Oncol; 2021; 11():584884. PubMed ID: 33898304
[TBL] [Abstract][Full Text] [Related]
50. Comprehensive analysis of a cuproptosis-related ceRNA network implicates a potential endocrine therapy resistance mechanism in ER-positive breast cancer.
Zhang D; Lu W; Zhuo Z; Wang Y; Zhang W; Zhang M
BMC Med Genomics; 2023 May; 16(1):96. PubMed ID: 37143115
[TBL] [Abstract][Full Text] [Related]
51. A Prognostic Model Based on the Immune-related Genes in Colon Adenocarcinoma.
Sun YL; Zhang Y; Guo YC; Yang ZH; Xu YC
Int J Med Sci; 2020; 17(13):1879-1896. PubMed ID: 32788867
[No Abstract] [Full Text] [Related]
52. MACC1 Correlates with Tumor Progression and Immune Cell Infiltration of Colon Adenocarcinoma and is Regulated by the lncRNA ZFAS1/miR-642a-5p Axis.
Liu BX; Yang J; Zeng C; Chen Y
J Oncol; 2022; 2022():8179208. PubMed ID: 36545127
[TBL] [Abstract][Full Text] [Related]
53. Non-coding RNA Identification in Osteonecrosis of the Femoral Head Using Competitive Endogenous RNA Network Analysis.
Han N; Li Z
Orthop Surg; 2021 May; 13(3):1067-1076. PubMed ID: 33749138
[TBL] [Abstract][Full Text] [Related]
54. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks.
Yang L; Lu P; Yang X; Li K; Chen X; Qu S
Bioengineered; 2021 Dec; 12(2):12821-12838. PubMed ID: 34898376
[TBL] [Abstract][Full Text] [Related]
55. An epithelial-mesenchymal transition-related mRNA signature associated with the prognosis, immune infiltration and therapeutic response of colon adenocarcinoma.
Zhang Y; Li Y; Zuo Z; Li T; An Y; Zhang W
Pathol Oncol Res; 2023; 29():1611016. PubMed ID: 36910014
[No Abstract] [Full Text] [Related]
56. Identification of lncRNA/circRNA-miRNA-mRNA ceRNA Network as Biomarkers for Hepatocellular Carcinoma.
Chen S; Zhang Y; Ding X; Li W
Front Genet; 2022; 13():838869. PubMed ID: 35386284
[No Abstract] [Full Text] [Related]
57. Integrated Analysis of ceRNA Network Reveals Prognostic and Metastasis Associated Biomarkers in Breast Cancer.
Qian D; Zheng Q; Wu D; Ye B; Qian Y; Zhou T; Qiu J; Meng X
Front Oncol; 2021; 11():670138. PubMed ID: 34055638
[TBL] [Abstract][Full Text] [Related]
58. An integrated bioinformatic investigation of mitochondrial energy metabolism genes in colon adenocarcinoma followed by preliminary validation of CPT2 in tumor immune infiltration.
Cao Z; Lin J; Fu G; Niu L; Yang Z; Cai W
Front Immunol; 2022; 13():959967. PubMed ID: 36177002
[TBL] [Abstract][Full Text] [Related]
59. Integrated Analysis of Competitive Endogenous RNA Networks in Acute Ischemic Stroke.
Wu Z; Wei W; Fan H; Gu Y; Li L; Wang H
Front Genet; 2022; 13():833545. PubMed ID: 35401659
[No Abstract] [Full Text] [Related]
60.
Sun Y; Li L; Yao W; Liu X; Yang Y; Ma B; Xue D
Front Genet; 2021; 12():762160. PubMed ID: 34795697
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
